MicroPort Scientific Corp is a leading healthcare company based in China with a focus on developing and marketing a wide range of medical devices. With a high ESG risk rating score of 32.1, the company operates in eight segments, including cardiovascular devices, orthopedics devices, cardiac rhythm management devices, endovascular & peripheral vascular devices, neurovascular devices, heart valve devices, surgical robot devices, and surgical devices. Their primary revenue comes from the People's Republic of China (PRC).